During the past decade, Alexandre Biasi Cavalcanti conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alexandre Biasi Cavalcanti" #1 collaborator was "Brazilian Research in Intensive Care Network (BRICNet)" with 1 trials as a collaborator, "D'Or Institute for Research and Education" with 1 trials as a collaborator and "Sociedade Hospital Samaritano" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Alexandre Biasi Cavalcanti" are "Acute Kidney Injury" (1 trials), "Acute Respiratory Distress Syndrome" (1 trials), "Critical Care" (1 trials), "Critical Illness" (1 trials) and "Mechanical Ventilation" (1 trials). Many other conditions were trialed in "Alexandre Biasi Cavalcanti" in a lesser frequency.

Most popular intervention types in "Alexandre Biasi Cavalcanti" are "Other" (2 trials), "Behavioral" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Conventional ventilation" (1 trials), "Daily checklist and clinician prompting" (1 trials), "Driving pressure limited ventilation" (1 trials), "Fast Infusion Speed" (1 trials) and "Plasma-Lyte" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alexandre Biasi Cavalcanti" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Alexandre Biasi Cavalcanti". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Alexandre Biasi Cavalcanti, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Alexandre Biasi Cavalcanti, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".